HER2 Support Group Forums - View Single Post - Immune function marker does not predict benefit of trastuzumab in HER-2+ breast cance

News · 12-15-2014, 03:16 AM

A marker of immune function that predicts for better outcomes in patients treated with chemotherapy for triple negative breast cancer is also linked to improved prognosis in patients treated with...

More...

12-15-2014, 03:16 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,983	Immune function marker does not predict benefit of trastuzumab in HER-2+ breast cance A marker of immune function that predicts for better outcomes in patients treated with chemotherapy for triple negative breast cancer is also linked to improved prognosis in patients treated with... More...